HUB Investment Partners’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Sell
27,444
-2,218
-7% -$58.1K 0.02% 438
2026
Q1
$630K Buy
29,662
+4,171
+16% +$83.4K 0.02% 478
2025
Q4
$416K Buy
25,491
+3,727
+17% +$56.3K 0.01% 541
2025
Q3
$254K Buy
21,764
+8,615
+66% +$112K 0.01% 610
2025
Q2
$152K Buy
+13,149
New +$120K 0.01% 649

Other funds holding TXG

HUB Investment Partners's TXG Position: Q2 2026 in Review

HUB Investment Partners reduced its 10x Genomics (TXG) stake by 7.5% in Q2 2026, selling an estimated $58.1K and leaving 27,444 shares worth $1.05M. The position accounts for 0.02% of the portfolio, ranked #438.

HUB Investment Partners first reported a position in TXG in Q2 2025 and has held it in 5 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • HUB Investment Partners held 27,444 shares of 10x Genomics worth $1.05M as of Q2 2026.
  • HUB Investment Partners sold 2,218 10x Genomics shares in Q2 2026, an estimated $58.1K.
  • 10x Genomics made up 0.02% of HUB Investment Partners's portfolio in Q2 2026, its #438 holding.
  • HUB Investment Partners first reported a position in 10x Genomics in Q2 2025 and has held it in 5 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.